AU Patent

AU2017268840B2 — Materials architecture for gastric residence systems

Assigned to Nortiva Bio Inc · Expires 2022-02-10 · 4y expired

What this patent protects

The invention provides gastric residence systems with specifically tailored architectures and methods for making such systems. The components of the gastric residence systems can be manufactured by three-dimensional printing or by co-extrusion. The ability to construct precise ar…

USPTO Abstract

The invention provides gastric residence systems with specifically tailored architectures and methods for making such systems. The components of the gastric residence systems can be manufactured by three-dimensional printing or by co-extrusion. The ability to construct precise architectures for the systems provides excellent control over drug release, in vivo stability, and residence time of the systems.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017268840B2
Jurisdiction
AU
Classification
—
Expires
2022-02-10
Drug substance claim
No
Drug product claim
No
Assignee
Nortiva Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.